Mark McCamish
Direktor/Vorstandsmitglied bei AVADEL PHARMACEUTICALS PLC
Vermögen: 1 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Mark McCamish
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
The Pennsylvania State University
239
| College/University | Other Consumer Services | 239 |
| Public Company | Medical Specialties | 84 | |
University of California, Santa Barbara
62
| College/University | Other Consumer Services | 62 |
| Private Company | Biotechnology | 25 | |
| Public Company | Real Estate Development | 20 | |
| Public Company | Pharmaceuticals: Major | 18 | |
| Subsidiary | Pharmaceuticals: Major | 13 | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 12 | |
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA
11
| Extinct | Drugstore Chains | 11 |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA.
7
| Extinct | Pharmaceuticals: Major | 7 |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish.
7
| Holding Company | Biotechnology | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark McCamish
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| KITE PHARMA INC | Biotechnology | Founder Chief Executive Officer Director/Board Member Private Equity Investor Corporate Secretary Private Equity Investor | |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Miscellaneous Commercial Services | Director/Board Member Founder Chairman Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Compliance Officer Founder | |
| The University of Chicago | College/University | Doctorate Degree Masters Business Admin Masters Business Admin Undergraduate Degree | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Founder Private Equity Investor Consultant / Advisor | |
IDT Telecom, Inc.
 IDT Telecom, Inc. Specialty TelecommunicationsCommunications IDT Telecom, Inc. provides telecommunications services. The company is headquartered in Newark, NJ. | Specialty Telecommunications | General Counsel Chairman Director/Board Member | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Founder Director/Board Member | |
| ZEDGE, INC. | Packaged Software | Director/Board Member Corporate Secretary Director/Board Member | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder Founder Founder | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
Net2Phone, Inc.
 Net2Phone, Inc. Specialty TelecommunicationsCommunications Net2Phone, Inc. engages in the provision of voice-enhanced internet communications services. It offers business messaging, international calling, additional offerings, api integration, analytics, call blocking, call recording, chrome extension, company directory, live chat, mobile app, net2phojne portal, on hold options, ring groups, web calling, and voicemail options. The company was founded in 1996 and is headquartered in Newark, NJ. | Specialty Telecommunications | Chairman Director/Board Member Chief Executive Officer | |
| IDT CORPORATION | Major Telecommunications | General Counsel Founder General Counsel | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer General Counsel | |
| NOVARTIS AG | Pharmaceuticals: Major | Compliance Officer Public Communications Contact Corporate Officer/Principal | |
| IMMUNOMEDICS, INC. | Biotechnology | President Director/Board Member Sales & Marketing | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
| University of California, Berkeley | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Human Resources Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Investment Managers | Founder Chairman Private Equity Investor | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Director/Board Member Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Doctorate Degree Graduate Degree | |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Medical Specialties | Director/Board Member Founder | |
Patheon Pharmaceuticals, Inc.
 Patheon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Patheon, Inc., Patheon Pharmaceuticals, Inc. is a trusted end-to-end contract development and manufacturing organization partner for the pharmaceutical, biotech, and life sciences industries. The company is based in Durham, NC. Benefit from a single vendor along your entire development journey by relying on their clinical trial services’ support network and expertise. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| David Geffen School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Biotechnology | Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| AZITRA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| BEYONDSPRING INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| Abbott Fund | President President | ||
Banner Life Sciences LLC
 Banner Life Sciences LLC Pharmaceuticals: MajorHealth Technology Banner Life Sciences LLC operates as clinical-stage pharmaceutical company. The company is headquartered in High Point, NC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Graduate Degree | |
Pheast Therapeutics Inc
 Pheast Therapeutics Inc BiotechnologyHealth Technology Pheast Therapeutics Inc is a pre-clinical stage immuno-oncology company that focuses on targeting cancer immune evasion pathways to activate the innate immune system in the fight against cancer. The company is based in Palo Alto, CA. Pheast aims to develop novel therapies for some of the most difficult-to-treat and aggressive cancers, as well as women's cancers including ovarian cancer and breast cancer. The company was founded in 2020 and is led by scientific experts in innate immunity and cancer immunotherapy. Jacopo Leonardi has been the CEO of the company since 2023. | Biotechnology | Founder Founder | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chairman | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Founder Director/Board Member |
Statistik
International
| Vereinigte Staaten | 46 |
| Deutschland | 2 |
| Schweiz | 2 |
| Vereinigtes Königreich | 2 |
| China | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 14 |
| Finance | 5 |
| Commercial Services | 4 |
| Communications | 4 |
Operativ
| Director/Board Member | 501 |
| Corporate Officer/Principal | 230 |
| Independent Dir/Board Member | 112 |
| Undergraduate Degree | 91 |
| Chairman | 82 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Joshua Kazam | 43 |
| Jon Saxe | 43 |
| Arie Belldegrun | 42 |
| Ian Clark | 35 |
| Mark McDade | 35 |
| Helen Kim | 33 |
| Chris Schaepe | 33 |
| Jeff Bird | 30 |
| Howard Jonas | 27 |
| Faheem Hasnain | 27 |
| Dennis J. Henner | 26 |
| Leonard Patrick Gage | 26 |
| Christopher Lowe | 25 |
| William Kaelin | 22 |
| Jakob Loven | 19 |
- Börse
- Insiders
- Mark McCamish
- Unternehmensverbindungen
